68Ga-DOTA-Exendin-4 PET/CT and 68Ga-DOTA-NOC PET/CT in localization of clinically suspected insulinomas.

被引:0
|
作者
Arunraj, Sreedharan [3 ]
Damle, Nishikant [3 ]
Gupta, Yashdeep [1 ]
Pal, Sujoy [2 ]
Sharma, Mehar [4 ]
Rajeev, Kumar [3 ]
Sharma, Anshul [3 ]
Bal, Chandrasekhar [3 ]
机构
[1] All India Inst Med Sci, Dept Endocrinol, New Delhi, India
[2] All India Inst Med Sci, Dept Gastrointestinal Surg & Liver Transplantat, New Delhi, India
[3] All India Inst Med Sci, Dept Nucl Med, New Delhi, India
[4] All India Inst Med Sci, Dept Pathol, New Delhi, India
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
49
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Application of Ga68-DOTA-exendin-4 PET/CT to localize an occult insulinoma
    Cuthbertson, D. J.
    Banks, M.
    Khoo, B.
    Antwi, K.
    Christ, E.
    Campbell, F.
    Raraty, M.
    Wild, D.
    CLINICAL ENDOCRINOLOGY, 2016, 84 (05) : 789 - 791
  • [32] Preparation of 68Ga-DOTA-NOC for PET/CT evaluation of neuroendocrine tumors under an Expanded Access IND
    Green, Mark
    Mathias, Carla
    Fletcher, James
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [33] Is 68Ga-DOTA-NOC PET/CT indicated in patients with clinical, biochemical or radiological suspicion of neuroendocrine tumour?
    Ambrosini, Valentina
    Campana, Davide
    Nanni, Cristina
    Cambioli, Silvia
    Tomassetti, Paola
    Rubello, Domenico
    Fanti, Stefano
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (08) : 1278 - 1283
  • [34] Is 68Ga-DOTA-NOC PET/CT indicated in patients with clinical, biochemical or radiological suspicion of neuroendocrine tumour?
    Valentina Ambrosini
    Davide Campana
    Cristina Nanni
    Silvia Cambioli
    Paola Tomassetti
    Domenico Rubello
    Stefano Fanti
    European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39 : 1278 - 1283
  • [35] Early and Late 68Ga-DOTA-NOC PET/CT in somatostatin receptor (sstr) expressing organ and tumour
    Demirci, E.
    Ocak, M.
    Kabasakal, L.
    Decristoforo, C.
    Ozsoy, Y.
    Araman, A.
    Uslu, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S281 - S281
  • [36] Improved Localization of Insulinomas Using 68 Ga-NODAGA-Exendin-4 PET/CT
    Boss, Marti
    Eriksson, Olof
    Mikkola, Kirsi
    Eek, Annemarie
    Brom, Maarten
    Buitinga, Mijke
    Brouwers, Adrienne H.
    Velikyan, Irina
    Waser, Beatrice
    Kauhanen, Saila
    Solin, Olof
    Marciniak, Camille
    Eriksson, Barbro
    Reubi, Jean-Claude
    Aveline, Cyrielle
    Wild, Damian
    Pattou, Francois
    Talbot, Jean-Noel
    Hofland, Johannes
    Sundin, Anders
    Nuutila, Pirjo
    Hermans, John
    Gotthardt, Martin
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (12) : 1959 - 1964
  • [37] 68Ga-DOTA-NOC: a new PET tracer for evaluating patients with bronchial carcinoid
    Ambrosini, Valentina
    Castellucci, Paolo
    Rubello, Domenico
    Nanni, Cristina
    Musto, Alessandra
    Allegri, Vincenzo
    Montini, Gian Carlo
    Mattioli, Sandro
    Grassetto, Gaia
    Al-Nahhas, Adil
    Franchi, Roberto
    Fanti, Stefano
    NUCLEAR MEDICINE COMMUNICATIONS, 2009, 30 (04) : 281 - 286
  • [38] Highly variable biodistribution of 68Ga labeled somatostatin analogues 68Ga-DOTA-NOC and 68Ga-DOTA-TATE in neuroendocrine tumors: clinical implications for somatostatin receptor directed PET/CT
    Cheng, Monica
    Tann, Mark
    HEPATOBILIARY SURGERY AND NUTRITION, 2022,
  • [39] Preliminary experience on the use of 68Ga-DOTA-NOC PET to study patients with paraganglioma
    Ambrosini, Valentina
    Castellucci, Paolo
    Musto, Alessandra
    Allegri, Vincenzo
    Montini, Giancarlo
    Rubello, Domenico
    Nanni, Cristina
    Fanti, Stefano
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [40] Oncogenic osteomalacia: Can 68Ga-DOTA-NOC PET/CT pick the culprit lesion amongst multiple lesions?
    Singh, Deepa
    Gambhir, Sanjay
    Arya, Amitabh
    Ravina, Mudalsha
    Verma, Shashwat
    Barai, Sukanta
    Sankar, Gowri
    Siddegowda, Murthy
    Kumar, Narvesh
    Dubey, Veeresh
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55